Researchers identify potential new strategy to treat ovarian cancer
4/29/2014
Scientists studying cancerous tumour tissues in a laboratory believe they have identified a potential new strategy to treat ovarian cancer - which affects around 7,000 women in the UK each year.
Two breath compounds could be associated with larynx cancer
4/29/2014
Researchers at the Rey Juan Carlos University and the Alcorcón Hospital (Madrid) have compared the volatile substances exhaled by eleven people with cancer of larynx, with those of another twenty...
Key regulator discovered in the pacemakers of the brain and heart
4/29/2014
Biologists have discovered how an outer shield over T-type channels change the electrochemical signaling of heart and brain cells.
Discovery may lead to development of a method for early detection of cancer cells
4/29/2014
A research team lead by Academy Professor Kari Rissanen at the University of Jyvaskyla has discovered a new water-soluble fluorescent detection system that is extremely sensitive to pyrophosphate...
Promising new approach targets cancer protein to slow tumor growth
4/29/2014
Sometimes a full-on assault isn't the best approach when dealing with a powerful enemy.
Moffitt Cancer Center researchers say clinical trials for a new experimental drug to treat acute myeloid leukemia (AML) are very promising.
Patient-focused enhanced recovery approach for colorectal surgery
4/29/2014
Changes in managing patients before, during and after colorectal surgery cut hospital stays by two days and reduced readmission rates, according to researchers who led a study of the approach at Duke...
Y chromosome loss: shorter life expectancy and higher cancer risk in men
4/29/2014
It is well known men have a shorter life expectancy than women. Now, researchers have suggested this difference may be due to a loss of the Y chromosome in blood cells.
Baker's yeast is giving scientists a better understanding of drug interactions
4/29/2014
When two or more medications are taken at the same time, one can suppress or enhance the effectiveness of the other. Similarly, one drug may magnify the toxicity of another.
New oral anticoagulant drugs that treat and prevent clots offer a much-needed alternative to warfarin, which has been used for more than 6 decades and has serious shortcomings.